Skip to content

Qualitative study to analyze the need and acceptance of a mobile app in oncological care

Qualitative study to analyze the need and acceptance of a mobile app in oncological care - BEDAK-onko

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022162
Enrollment
30
Registered
2020-08-25
Start date
2020-09-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: needs assessment and analysis of acceptance and user-friendliness of the app

Sponsors

Universitätsklinikum Freiburg, Tumorzentrum Freiburg - CCCF, Stiftungsprofessur Selbsthilfeforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: a) Patients with the primary diagnosis of cancer who are treated or were treated in the University Hospital Freiburg because of cancer, who speak German and who have given written consent to participate. b) Participants in self-help groups on the subject of cancer who are treated or were treated in the University Hospital Freiburg because of cancer, who speak German and who have given written consent to participate.

Exclusion criteria

Exclusion criteria: Minors, participants with language barriers, very low life expectancy, severe psychiatric diseas or assessment as “not able to agree”.

Design outcomes

Primary

MeasureTime frame
The study has two goals: First, a needs assessment should be made, in which the expectations, needs and fears of oncological patients regarding an app for oncological care are recorded. Furthermore, the app should be evaluated for user-friendliness and patient acceptance. The study uses qualitative methods and includes 2 sections: 1) Interviews without prior app use 2) Supported installation of the app and interviews after approx. 14 days of app use

Secondary

MeasureTime frame
Due to the explorative nature of the study, no explicit primary endpoint or explicit secondary endpoints are established.

Countries

Germany

Contacts

Public ContactLucy Raphaela Wolf

Universitätsklinikum Freiburg, Tumorzentrum / CCCF Freiburg, Stiftungsprofessur Selbsthilfeforschung

lucy.raphaela.wolf@uniklinik-freiburg.de+49 (0)761 270-71564

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026